AI is speeding up drug discovery by designing new medicines faster and cheaper. It scans data, creates new molecules, and ...

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.

A group of vaccine-skeptical doctors and mandate opponents is challenging the CDC’s childhood immunization schedule in ...

For savvy investors looking for long-term businesses that not only dominate their industries today but also have the ...

ORLANDO, FL, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Stellar Market Research examines the growth rate of the Endocrinology Drugs Market during the forecasted period 2025-2032 The ...

The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates ...

Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...

Eli Lilly (LLY) has signed a $1.3 billion deal with privately held biotechnology firm Superluminal Medicines that will see ...

Google issues cybersecurity warning as hackers exploit AI to steal passwords. FDA warns against unapproved sunscreens. Lilly ...

To provide a brief background, the TRAILBLAZER-ALZ 2 LTE study was a Phase 3, double-blind extension of the original ...

Fundsmith has invested in some excellent companies, but it has struggled to decide when to sell, says Max King ...

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes ...